RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Amyloid-beta peptide is central to the pathology of Alzheimer's disease, because it is neurotoxic--directly by inducing oxidant stress, and indirectly by activating microglia. A specific cell-surface acceptor site that could focus its effects on target cells has been postulated but not identified. Here we present evidence that the 'receptor for advanced glycation end products' (RAGE) is such a receptor, and that it mediates effects of the peptide on neurons and microglia. Increased expressing of RAGE in Alzheimer's disease brain indicates that it is relevant to the pathogenesis of neuronal dysfunction and death.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Yan et al. reported that Aβ peptides and Aβ oligomers can bind to RAGE receptor and activate glial cells.331”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [331]
In the citing paper
“Given that intracellular A β overload can induce oxidative stress and cell death [ 38-40 ]”
From Restores Aβ Clearance by Overcoming PCSK9–LRP1 Dysregulation and TRIB3‐Mediated Autophagy Blockade in Alzheimer's Disease (2026) · cites this paper as [38]
In the citing paper
“Enhancing A β uptake or efflux alone may increase intracellular A β -handling burden if autophagic degradation remains impaired [ 38-40 ].”
From Restores Aβ Clearance by Overcoming PCSK9–LRP1 Dysregulation and TRIB3‐Mediated Autophagy Blockade in Alzheimer's Disease (2026) · cites this paper as [38]
In the citing paper
“Apolipoprotein E3 (ApoE3), another key component of the lipoprotein‐like nanostructure, acts as an effective anti‐inflammatory molecule.[ 18 ]”
From Multifunctional Nanostructure RAP‐RL Rescues Alzheimer's Cognitive Deficits through Remodeling the Neurovascular Unit (2021) · cites this paper as [18]
In the citing paper
“In addition, a key component of RAP‐RL, ApoE3, has been shown to regulate pericyte‐mediated cerebrovascular integrity and anti‐inflammatory reaction.[ 18 , 19 ]”
From Multifunctional Nanostructure RAP‐RL Rescues Alzheimer's Cognitive Deficits through Remodeling the Neurovascular Unit (2021) · cites this paper as [18]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Osborn, L., Hession, C., Tizard, R., Vassallo, C., Luhowskyj, S., Chi-Rosso, G., & Lobb, R. (1989) · Cell · doi:10.1016/0092-8674(89)90775-7 · Cited by 1,689
Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C., Elliston, K., Stern, D., & Shaw, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,541
Self-citationNeurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Activation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
Self-citationThe Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151
Self-citationHensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086
Research works printed but not linked: 4
- Haass, C. & Selkoe, D. Cell 7, 1039–1042 (1994).
- Trojanowski, J. & Lee, V. Am. J. Pathol. 144, 449–453 (1994).
- Gumkowski, F. et al. Blood Vessels 24, 11–18 (1987).
- Brett, J. et al. Am. J. Pathol. 143, 1699–1712 (1993).
Cited by
Items 301–400 of 1,027
Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer’s Disease
Cioffi, F., Adam, R. H. I., & Broersen, K. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190863 · Cited by 204
Behl, C., & Moosmann, B. (2002) · Biological Chemistry · doi:10.1515/bc.2002.053 · Cited by 203
“It was also proposed that Aβ-aggregates stimulate ROS generation via binding to the receptor for advanced glycation endproducts (RAGE), which leads to the activation of a downstream NADH oxidase (Yan et al., 1996), but binding of Aβ to RAGE is not a necessary step for Aβ toxicity in vitro (Liu et al.”
BackgroundFunctional mitochondria are required for amyloid β‐mediated neurotoxicity
Cardoso, S. M., Santos, S., Swerdlow, R. H., & Oliveira, C. R. (2001) · The FASEB Journal · doi:10.1096/fj.00-0561fje · Cited by 203
Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases
Grammas, P., Martinez, J., & Miller, B. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001918 · Cited by 202
Advanced glycoxidation end products in chronic diseases—clinical chemistry and genetic background
Kalousová, M., Zima, T., Tesař, V., Dusilová-Sulková, S., & Škrha, J. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2005.03.024 · Cited by 203
Yates, S. L., Burgess, L. H., Kocsis‐Angle, J., Antal, J. M., Dority, M. D., Embury, P. B., Piotrkowski, A. M., & Brunden, K. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741017.x · Cited by 202
Aβ-peptides enhance vasoconstriction in cerebral circulation
Niwa, K., Porter, V. A., Kazama, K., Cornfield, D., Carlson, G. A., & Iadecola, C. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.6.h2417 · Cited by 202
Molecular links between Alzheimer’s disease and diabetes mellitus
Yang, Y., & Song, W. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.009 · Cited by 201
Origlia, N., Righi, M., Capsoni, S., Cattaneo, A., Fang, F., Stern, D. M., Chen, J. X., Schmidt, A. M., Arancio, O., Yan, S. D., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0204-08.2008 · Cited by 202
“Specific antibodies to RAGE have been described in our previous studies (Yan et al., 1996) and purified rabbit IgG was used as a control (Bethyl, Montgomery, TX).”
BackgroundMethodSelf-citationIshihara, K., Tsutsumi, K., Kawane, S., Nakajima, M., & Kasaoka, T. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00846-9 · Cited by 201
Mechanisms of islet amyloidosis toxicity in type 2 diabetes
Abedini, A., & Schmidt, A. M. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.017 · Cited by 200
Self-citationMicroglia: Multitasking Specialists of the Brain
Casano, A. M., & Peri, F. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.01.018 · Cited by 209
“In particular, microglia are thought to be poor phagocytes for b-amyloid engulfment and to promote AD pathology by releasing proinflammatory cytokines (Yan et al., 1996; Xie et al., 2006; Griciuc et al., 2013).”
BackgroundType 2 Diabetes and Cognitive Impairment: Linking Mechanisms
Luchsinger, J. A. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-111433 · Cited by 199
Neurotoxicity of Advanced Glycation End-Products for Cultured Cortical Neurons
Takeuchi, M., Bucala, R., Suzuki, T., Ohkubo, T., Yamazaki, M., Koike, T., Kameda, Y., & Makita, Z. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.12.1094 · Cited by 198
Milardi, D., Gazit, E., Radford, S. E., Xu, Y., Gallardo, R. U., Caflisch, A., Westermark, G. T., Westermark, P., Rosa, C. L., & Ramamoorthy, A. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00981 · Cited by 196
Rosas-Ballina, M., Goldstein, R. S., Gallowitsch-Puerta, M., Yang, L., Valdés-Ferrer, S. I., Patel, N. B., Chavan, S., Al-Abed, Y., Yang, H., & Tracey, K. J. (2009) · Molecular Medicine · doi:10.2119/molmed.2009.00039 · Cited by 195
Correia, S. C., Santos, R. X., Carvalho, C., Cardoso, S., Candeias, E., Santos, M. S., Oliveira, C. R., & Moreira, P. I. (2012) · Brain Research · doi:10.1016/j.brainres.2011.12.063 · Cited by 195
Hippocampal RAGE immunoreactivity in early and advanced Alzheimer’s disease
Miller, M. C., Tavares, R., Johanson, C. E., Hovanesian, V., Donahue, J. E., Gonzalez, L., Silverberg, G. D., & Stopa, E. G. (2008) · Brain Research · doi:10.1016/j.brainres.2008.06.124 · Cited by 194
“The data that we collected support the general hypothesis that hippocampal microvascular RAGE immunoreactivity increases in advanced AD in human patients [Yan et al. 1996; Donahue et al. 2006].”
ResultWang, Q., Rowan, M. J., & Anwyl, R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0233-04.2004 · Cited by 193
“We suggest that A initially activates a receptor, which could be a scavenger receptor (El Khoury et al., 1996), a receptor for advanced glycation end products ( Yan et al., 1996 ), a receptor complex including a scavenger and integrin proteins (Bamberger et al., 2003), or the tumor necrosis factor type I receptor (TNF…”
BackgroundAβ ion channels. Prospects for treating Alzheimer's disease with Aβ channel blockers
Arispe, N., Diaz, J. C., & Simakova, O. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.03.014 · Cited by 193
“Several candidate cell surface receptors have been considered, these include tachykinin receptors [35,36], serpin – enzyme complex (SEC) receptors [37,38], integrins; P75 neurotrophin receptor; and receptor for advance glycosylation end-products (RAGE) [39].”
BackgroundRAGE signaling in inflammation and arterial aging
Lin, L. (2009) · Frontiers in Bioscience · doi:10.2741/3315 · Cited by 192
β-Amyloid peptides as direct cholinergic neuromodulators: a missing link?
Auld, D. S., Kar, S., & Quirion, R. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01144-2 · Cited by 196
Dattilo, B. M., Fritz, G., Leclerc, E., Vander Kooi, C. W., Heizmann, C. W., & Chazin, W. J. (2007) · Biochemistry · doi:10.1021/bi7003735 · Cited by 192
Pleiotropic roles of formyl peptide receptors
LE, Y., OPPENHEIM, J., & WANG, J. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00003-x · Cited by 192
Niwa, K., Carlson, G. A., & Iadecola, C. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200012000-00005 · Cited by 191
Animal models of Alzheimer's disease and evaluation of anti-dementia drugs
Yamada, K., & Nabeshima, T. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00081-4 · Cited by 190
The role of scavenger receptors in pathogen recognition and innate immunity
Mukhopadhyay, S., & Gordon, S. (2004) · Immunobiology · doi:10.1016/j.imbio.2004.02.004 · Cited by 191
Mori, T., Koyama, N., Guillot-Sestier, M.-V., Tan, J., & Town, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055774 · Cited by 189
“It is well-accepted that oxidative stress contributes to AD neuropathology [39,40].”
BackgroundAlzheimer's Disease: Redox Dysregulation As a Common Denominator for Diverse Pathogenic Mechanisms
von Bernhardi, R., & Eugenín, J. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4082 · Cited by 190
Pathological role of hypoxia in Alzheimer's disease
Zhang, X., & Le, W. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.07.033 · Cited by 188
“They express receptors such as class A scavenger receptor, CD36 and receptor for advanced-glycosylation endproducts (RAGE) (El Khoury et al., 1998; Yan et al., 1996), and secrete Aβ-degrading enzymes, such as NEP and IDE (Leissring et al., 2003) to promote the clearance and phagocytosis of Aβ.”
BackgroundThe Conserved Scavenger Receptor Cysteine-Rich Superfamily in Therapy and Diagnosis
Martínez, V. G., Moestrup, S. K., Holmskov, U., Mollenhauer, J., & Lozano, F. (2011) · Pharmacological Reviews · doi:10.1124/pr.111.004523 · Cited by 188
“Indeed, aggregated and/or glycated -amyloid protein can be endocytosed by SR-AI/II-expressing microglial cells located in the vicinity of senile plaques from patients with Alzheimer’s disease (Christie et al., 1996; Yan et al., 1996).”
BackgroundInsulin receptors and insulin actions in the nervous system
Freychet, P. (2000) · Diabetes/Metabolism Research and Reviews · doi:10.1002/1520-7560(200011/12)16:6<390::aid-dmrr161>3.0.co;2-t · Cited by 48
Microglial Scavenger Receptors and Their Roles in the Pathogenesis of Alzheimer's Disease
Wilkinson, K., & El Khoury, J. (2012) · International Journal of Alzheimer's Disease · doi:10.1155/2012/489456 · Cited by 186
“RAGE (receptor for advanced glycation end products) is a member of the immunoglobulin superfamily of receptors [78] expressed on endothelial cells [79] and microglia which is capable of binding many ligands including Aβ [80], AGEs (advanced glycation end products) and S100 protein [81].”
BackgroundImmunological aspects of microglia: relevance to Alzheimer's disease
Benveniste, E. N., Nguyen, V. T., & O'Keefe, G. M. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00045-6 · Cited by 187
Biology of Aβ Amyloid in Alzheimer's Disease
Wisniewski, T., Ghiso, J., & Frangione, B. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0147 · Cited by 134
Clearance of amyloid β-peptide from brain: transport or metabolism?
Zlokovic, B. V., Yamada, S., Holtzman, D., Ghiso, J., & Frangione, B. (2000) · Nature Medicine · doi:10.1038/77397 · Cited by 186
Reactive Oxygen Species Mediate Cellular Damage in Alzheimer Disease
Perry, G., Castellani, R. J., Hirai, K., & Smith, M. A. (1998) · Journal of Alzheimer's Disease · doi:10.3233/jad-1998-1103 · Cited by 185
Ono, K., Hamaguchi, T., Naiki, H., & Yamada, M. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.03.002 · Cited by 184
“It was proposed that this interaction is not random, but is rather mediated by the receptor for advanced glycation endproducts (RAGE) [18].”
BackgroundRAGE: a novel biological and genetic marker for vascular disease
Kalea, A. Z., Schmidt, A. M., & Hudson, B. I. (2009) · Clinical Science · doi:10.1042/cs20080494 · Cited by 183
Self-citationChornenkyy, Y., Wang, W., Wei, A., & Nelson, P. T. (2019) · Brain Pathology · doi:10.1111/bpa.12655 · Cited by 184
Deane, R., Sagare, A., & Zlokovic, B. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784705487 · Cited by 183
Alzheimer’s Disease and Type 2 Diabetes: Multiple Mechanisms Contribute to Interactions
Jayaraman, A., & Pike, C. J. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0476-2 · Cited by 182
Fu, H., Liu, B., Frost, J. L., Hong, S., Jin, M., Ostaszewski, B., Shankar, G. M., Costantino, I. M., Carroll, M. C., Mayadas, T. N., et al. (2012) · Glia · doi:10.1002/glia.22331 · Cited by 180
“2007) (Yan et al. 1996), and the receptor complex composed of B-class scavenger receptor CD36, an integrin-associated protein (CD47) and α6β1-integrin (Koenigsknecht and Landreth 2004).”
BackgroundTeissier, T., & Boulanger, É. (2019) · Biogerontology · doi:10.1007/s10522-019-09808-3 · Cited by 179
“This interaction plays a role in Ab neurotoxicity and circulating Ab influx into the brain (Deane et al. 2012; Yan et al. 1996).”
BackgroundWalker, D. G., Link, J., Lue, L.-F., Dalsing-Hernandez, J. E., & Boyes, B. E. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0705377 · Cited by 180
LEE, H., CASADESUS, G., ZHU, X., TAKEDA, A., PERRY, G., & SMITH, M. A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1297.001 · Cited by 179
Nuclear factor-κB/Rel proteins
Grilli, M., & Memo, M. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00214-7 · Cited by 180
RAGE and Alzheimer's Disease: A Progression Factor for Amyloid-β-Induced Cellular Perturbation?
Yan, S. D., Bierhaus, A., Nawroth, P. P., & Stern, D. M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1030 · Cited by 177
Self-citationGlycation exacerbates the neuronal toxicity of β-amyloid
Li, X.-H., Du, L.-L., Cheng, X.-S., Jiang, X., Zhang, Y., Lv, B.-L., Liu, R., Wang, J.-Z., & Zhou, X.-W. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.180 · Cited by 177
Stefani, M. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.03.002 · Cited by 177
“Since 1996, the receptor for advanced glycation end products (RAGE) has been proposed as a major candidate as amyloid receptor (Yan et al., 1996).”
BackgroundLi, R., Yang, L., Lindholm, K., Konishi, Y., Yue, X., Hampel, H., Zhang, D., & Shen, Y. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4580-03.2004 · Cited by 177
“On the other hand, neuronal death mediated by the Apaf-NF-B signal cascade might interact with more than one surface protein of neurons, such as APP itself (Lorenzo et al., 2000), a receptor for advanced glycation end products (Yan et al., 1996), or both.”
BackgroundBrain iron deposition and the free radical-mitochondrial theory of ageing
Schipper, H. M. (2004) · Ageing Research Reviews · doi:10.1016/j.arr.2004.02.001 · Cited by 177
Antioxidant gene therapy against neuronal cell death
Navarro-Yepes, J., Zavala-Flores, L., Anandhan, A., Wang, F., Skotak, M., Chandra, N., Li, M., Pappa, A., Martinez-Fong, D., Del Razo, L. M., et al. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.007 · Cited by 176
“The receptor for advanced glycation end products (RAGE) has also been proposed to mediate Aβ's pro-oxidant effects (Yan et al., 1996).”
Sousa, M. M., Yan, S. D., Stern, D., & Saraiva, M. J. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780116 · Cited by 176
“…Shen et al, 1998; Yaar et al, 1997; Yan et al, 1996), and recent attention has focused on the receptor for advanced glycation endproducts (RAGE) because of its potential to function as a signal transduction receptor for b-sheet fibrils (Du Yan et al, 1997; Kindy et al, 1999; Yan et al, 1996, 1999).”
BackgroundMethodSelf-citationUdan, M. L. D., Ajit, D., Crouse, N. R., & Nichols, M. R. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05001.x · Cited by 174
Microglia Activation and Anti-inflammatory Regulation in Alzheimer’s Disease
Lue, L.-F., Kuo, Y.-M., Beach, T., & Walker, D. G. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8106-8 · Cited by 176
“microglial inflammatory responses [126].”
Burstein, A. H., Sabbagh, M., Andrews, R., Valcarce, C., Dunn, I., & Altstiel, L. (2018) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2018.18 · Cited by 171
Butterfield, D. A., Griffin, S., Munch, G., & Pasinetti, G. M. (2002) · Journal of Alzheimer's Disease · doi:10.3233/jad-2002-4309 · Cited by 175
Approaches to discovery and characterization of inhibitors of amyloid β-peptide polymerization
Findeis, M. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00034-x · Cited by 174
Amphoterin as an extracellular regulator of cell motility: from discovery to disease
Huttunen, H. J., & Rauvala, H. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2003.01301.x · Cited by 173
Activation of the CB2 receptor system reverses amyloid-induced memory deficiency
Wu, J., Bie, B., Yang, H., Xu, J. J., Brown, D. L., & Naguib, M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.06.011 · Cited by 171
“Microglia play an important role in promoting the clearance and phagocytosis of A (Rogers et al., e o a A p l t d 1 m m c A a A A D C A a C R 2002; Streit, 2004; Yan et al., 1996, 2006) and there is an inverse relationship between cytokine production and A clearance (Hickman et al., 2008).”
Jan, A., Adolfsson, O., Allaman, I., Buccarello, A.-L., Magistretti, P. J., Pfeifer, A., Muhs, A., & Lashuel, H. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.172411 · Cited by 173
Peptide Aptamers: Development and Applications
Reverdatto, S., Burz, D., & Shekhtman, A. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150413153143 · Cited by 171
Huttunen, H. J., Kuja-Panula, J., & Rauvala, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202515200 · Cited by 172
HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation
Nogueira-Machado, J. A., Volpe, C. M. D. O., Veloso, C. A., & Chaves, M. M. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.575360 · Cited by 170
Glycation—a sweet tempter for neuronal death
Kikuchi, S. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00273-4 · Cited by 169
Soluble RAGE: Therapy and biomarker in unraveling the RAGE axis in chronic disease and aging
Yan, S. F., Ramasamy, R., & Schmidt, A. M. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.01.013 · Cited by 169
“Amyloid-β peptide and β-sheet fibrils are ligands of RAGE implicated in Alzheimer’s disease and amyloidoses [20].”
BackgroundSelf-citationPostprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics
Abbatecola, A. M., Rizzo, M. R., Barbieri, M., Grella, R., Arciello, A., Laieta, M. T., Acampora, R., Passariello, N., Cacciapuoti, F., & Paolisso, G. (2006) · Neurology · doi:10.1212/01.wnl.0000224760.22802.e8 · Cited by 168
Chami, L., & Checler, F. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-52 · Cited by 168
Wan, W., Cao, L., Liu, L., Zhang, C., Kalionis, B., Tai, X., Li, Y., & Xia, S. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13122 · Cited by 168
“In microglia, RAGE amplifies Ab-mediated inflammatory response (Yan et al. 1996).”
BackgroundThe amyloid precursor protein of Alzheimer’s disease and the Aβ peptide
Storey, & Cappai (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00164.x · Cited by 169
Schmidt, A. M., & Stern, D. M. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00311-8 · Cited by 167
Self-citationModeling microglial activation in Alzheimer's disease with human postmortem microglial cultures
Lue, L. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00311-6 · Cited by 166
Hudson, B. I., Bucciarelli, L. G., Wendt, T., Sakaguchi, T., Lalla, E., Qu, W., Lu, Y., Lee, L., Stern, D. M., Naka, Y., et al. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.030 · Cited by 165
Self-citationDá Mesquita, S., Ferreira, A. C., Sousa, J. C., Correia-Neves, M., Sousa, N., & Marques, F. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.014 · Cited by 166
Innate immune activation in neurodegenerative diseases
Castro-Gomez, S., & Heneka, M. T. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.010 · Cited by 162
Regulation of cell migration by amphoterin
Fages, C., Nolo, R., Huttunen, H. J., Eskelinen, E.-L., & Rauvala, H. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.4.611 · Cited by 166
Microglial Activation in Alzheimer Disease: Association with APOE Genotype
Egensperger, R., Kösel, S., von Eitzen, U., & Graeber, M. B. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00166.x · Cited by 164
AGEs/RAGE complex upregulates BACE1 via NF-κB pathway activation
Guglielmotto, M., Aragno, M., Tamagno, E., Vercellinatto, I., Visentin, S., Medana, C., Catalano, M. G., Smith, M. A., Perry, G., Danni, O., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.026 · Cited by 163
“The role of RAGE in the pathogenesis of AD has been extensively studied, because it also binds A (Yan et al., 1996), causing an increase in A influx into the brain across the blood-brain barrier (Arancio et al.”
Activation of immune signals during organ transplantation
Li, Q., & Lan, P. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01377-9 · Cited by 159
Microglia Demonstrate Age-Dependent Interaction with Amyloid-β Fibrils
Floden, A. M., & Combs, C. K. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101014 · Cited by 162
“Although only a subset of putative A interacting proteins were analyzed due to limitations in sample amount, quantification of Western blot analysis demonstrated that only CD36 out of a number of putative A interacting proteins demonstrated an age dependent decrease in protein levels with significantly less protein at…”
Thal, D. R., Holzer, M., Rüb, U., Waldmann, G., Günzel, S., Zedlick, D., & Schober, R. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7380 · Cited by 162
The physiology of the β‐amyloid precursor protein intracellular domain AICD
Pardossi‐Piquard, R., & Checler, F. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07475.x · Cited by 159
“This is not anecdotic since the latter species is more prone to aggregation (Burdick et al. 1992), more toxic (El Khoury et al. 1996; Yan et al. 1996) and often selectively modulated by PS-associated pathogenic mutations (Suh and Checler 2002).”
Activation of mTOR: a culprit of Alzheimer’s disease?
Cai, Z., Zhou, Y., Xiao, M., Yan, L.-J., & He, W. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s75717 · Cited by 161
Qosa, H., Abuznait, A. H., Hill, R. A., & Kaddoumi, A. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120319 · Cited by 159
“On the other hand, receptor for advanced glycation end products (RAGE) and low density lipoprotein receptor-related protein-2 (LRP2) are the major proteins that regulate A influx to the brain [15, 16].”
BackgroundSabbagh, M. N., Agro, A., Bell, J., Aisen, P. S., Schweizer, E., & Galasko, D. (2011) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318204b550 · Cited by 160
Protective role of heme oxygenase-1 in oxidative stress-induced neuronal injury
Le, W.-D., Xie, W.-J., & Appel, S. H. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990615)56:6<652::aid-jnr11>3.0.co;2-5 · Cited by 160
The role of an astrocytic NADPH oxidase in the neurotoxicity of amyloid beta peptides
Abramov, A. Y., & Duchen, M. R. (2005) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2005.1766 · Cited by 160
“…such as phorbol myristate acetate (PMA), which activates the enzyme through activation of protein kinase C (PKC) (Wautier et al. 2001) and to enhance ROS generation in response to activation by P2x receptors (which raise [Ca2C]c) of neutrophils from patients with familial AD (Yan et al. 1996).”
BackgroundThe role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APPSW mice
Wegiel, J. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00181-0 · Cited by 159
Pathologies Involving the S100 Proteins and Rage
HEIZMANN, C. W., ACKERMANN, G. E., & GALICHET, A. (2007) · Subcellular Biochemistry · doi:10.1007/978-1-4020-6191-2_5 · Cited by 158
Expression of Scavenger Receptors in Glial Cells
Alarcón, R., Fuenzalida, C., Santibáñez, M., & von Bernhardi, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414686200 · Cited by 158
Alzheimer’s Disease Pathogenesis: Role of Autophagy and Mitophagy Focusing in Microglia
Eshraghi, M., Adlimoghaddam, A., Mahmoodzadeh, A., Sharifzad, F., Yasavoli-Sharahi, H., Lorzadeh, S., Albensi, B. C., & Ghavami, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073330 · Cited by 158
Tiffany, H. L., Lavigne, M. C., Cui, Y.-H., Wang, J.-M., Leto, T. L., Gao, J.-L., & Murphy, P. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101031200 · Cited by 157
Properties of cytotoxic peptide-formed ion channels
Kourie, J. I., & Shorthouse, A. A. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.278.6.c1063 · Cited by 158
Ballance, W. C., Qin, E. C., Chung, H. J., Gillette, M. U., & Kong, H. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119292 · Cited by 156
Pereira, C., Santos, M. S., & Oliveira, C. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0241 · Cited by 156
RAGE and Soluble RAGE: Potential Therapeutic Targets for Cardiovascular Diseases
Koyama, H., Yamamoto, H., & Nishizawa, Y. (2007) · Molecular Medicine · doi:10.2119/2007-00087.koyama · Cited by 156
Zheng, F., Qin, C., Chang, Y. S., & Zhang, J. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.08.014 · Cited by 161
Role of Vascular Risk Factors and Vascular Dysfunction in Alzheimer's Disease
Dickstein, D. L., Walsh, J., Brautigam, H., Stockton, S. D., Gandy, S., & Hof, P. R. (2010) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20155 · Cited by 155
New insights into the metabolic and molecular basis for diabetic neuropathy
Sima, A. A. F. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3084-x · Cited by 169
Metadata
- Authors
- Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., Migheli, A., Nawroth, P., Stern, D., & Schmidt, A. M.
- Affiliations
- Columbia University (US)
- University of Turin (IT)
- Heidelberg University (DE)
- Venue
- Nature
- Published
- 1996-08
- Volume
- 382
- Issue
- 6593
- Pages
- 685-691
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2049167261
- Cited by
- 2,012
- References
- 44
- Citations by year
- 2026: 28 · 2025: 33 · 2024: 44 · 2023: 46 · 2022: 56 · 2021: 48 · 2020: 59 · 2019: 58 · 2018: 65 · 2017: 55 · 2016: 77 · 2015: 75 · 2014: 81 · 2013: 93 · 2012: 100
- FWCI
- 58.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- receptor for advanced glycation end products, RAGE, amyloid-beta, neurotoxicity, Alzheimer's disease, microglial activation, oxidative stress, neuronal cell death, cell surface receptors, neuroinflammation
- MeSH terms
- Receptor for Advanced Glycation End Products, Alzheimer Disease, Animals, Base Sequence, Cattle, Cell Line, Cells, Cultured, Endothelium, Vascular, Humans, Molecular Sequence Data, Neurons, Receptors, Immunologic, Biomarkers, Amyloid beta-Peptides, PC12 Cells, Glycation End Products, Advanced, Microglia, DNA Primers, Oxidative Stress, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.